Sunstone Medical, PC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Depression6 trials

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial

Lead sponsor

• Cybin IRL Limited3 trials
• atai Therapeutics, Inc.1 trial
• Sunstone Medical1 trial
• Usona Institute1 trial

Running trials

• Recruiting

  A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  NCT06793397· Phase 3· Cybin IRL Limited· Source

  Contact: Manish Agrawal, MD

• Enrolling by invitation

  Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

  NCT06605105· Phase 3· Cybin IRL Limited· Source

• Active, not recruiting

  Psilocybin for Major Depressive Disorder (MDD)

  NCT06308653· Phase 3· Usona Institute· Source

• Active, not recruiting

  Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

  NCT05947383· Phase 2· Sunstone Medical· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting

Closed trials

• Completed

  A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  NCT06524830· Phase 2· atai Therapeutics, Inc.· Source

• Completed

  "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

  NCT06564818· Phase 3· Cybin IRL Limited· Source